Volume 9 Issue 9, Sep 2024

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)

Volume 9 Issue 9, Sep 2024:
Article
Revealing the crucial roles of suppressive immune microenvironment in cardiac myxoma progression
Zedong Jiang,Qianlong Kang,Hong Qian,Zhijie Xu  ORCID: orcid.org/0000-0003-2047-883X,Huan Tong,Jiaqing Yang,Li Li,Renwei Li,Guangqi Li,Fei Chen,Nan Lin,Yunuo Zhao,Huashan Shi  ORCID: orcid.org/0000-0002-9958-9892,Juan Huang &…Xuelei Ma  ORCID: orcid.org/0000-0002-9148-5001 
Cardiac myxoma is a commonly encountered tumor within the heart that has the potential to be life-threatening. However, the cellular composition of this condition is still not well understood. To fill this gap, we analyzed 75,641 cells from cardiac myxoma tissues based on single-cell sequencing. We defined a population of myxoma cells, which exhibited a resemblance to fibroblasts, yet they were distinguished by an increased expression of phosphodiesterases and genes associated with cell proliferation, differentiation, and adhesion. The clinical relevance of the cell populations indicated a higher proportion of myxoma cells and M2-like macrophage infiltration, along with their enhanced spatial interaction, were found to significantly contribute to the occurrence of embolism. The immune cells surrounding the myxoma exhibit inhibitory characteristics, with impaired function of T cells characterized by the expression of GZMK and TOX, along with a substantial infiltration of tumor-promoting macrophages expressed growth factors such as PDGFC. Furthermore, in vitro co-culture experiments showed that macrophages promoted the growth of myxoma cells significantly. In summary, this study presents a comprehensive single-cell atlas of cardiac myxoma, highlighting the heterogeneity of myxoma cells and their collaborative impact on immune cells. These findings shed light on the complex pathobiology of cardiac myxoma and present potential targets for intervention.